Koyfin Home > Directory > Health Care > Akebia Therapeutics > Long-Term Debt

Akebia Therapeutics Long-Term Debt Chart (AKBA)

Akebia Therapeutics annual/quarterly Long-Term Debt from 2019 to 2020.
  • Akebia Therapeutics Long-Term Debt for the quarter ending June 06, 2020 was $76m
  • Akebia Therapeutics Long-Term Debt for the last 12 months ending June 06, 2020 was $76m
Other Cash Flow Metrics:
  • Akebia Therapeutics Cash Flow from Operations for the quarter ending December 12, 2018 was $-74m a 72.41% decrease of -53m year over year
  • Akebia Therapeutics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-92m a 89.67% decrease of -82m year over year
  • Akebia Therapeutics Total Revenue for the quarter ending December 12, 2018 was $60m a 23.26% increase of 14m year over year
View Chart On Koyfin

Quarterly AKBA Long-Term Debt Data

06/2020$76m
03/2020$76m
12/2019$76m

Annual AKBA Long-Term Debt Data

2019$76m